| Michael E Fiorina, DO | |
|
109 Technology Drive, Suite A, Butler, PA 16001-1785 | |
| (724) 431-0300 | |
| (724) 431-0301 |
| Full Name | Michael E Fiorina |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 109 Technology Drive, Butler, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235239195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS0089347L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Butler Memorial Hospital | Butler, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butler Medical Providers | 7416840160 | 308 |
News Archive
Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.
A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.
› Verified 9 days ago
| Entity Name | Butler Medical Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619493046 PECOS PAC ID: 7416840160 Enrollment ID: O20040205000830 |
News Archive
Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.
A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.
› Verified 9 days ago
| Entity Name | Fiorina Fam Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346332665 PECOS PAC ID: 6103870886 Enrollment ID: O20050304000773 |
News Archive
Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.
A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael E Fiorina, DO 109 Technology Drive, Suite A, Butler, PA 16001-1785 Ph: (724) 431-0300 | Michael E Fiorina, DO 109 Technology Drive, Suite A, Butler, PA 16001-1785 Ph: (724) 431-0300 |
News Archive
Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.
A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.
Scientists from King's College London and Imperial College London believe they have discovered a key element in the development of chronic asthma. Their research has been published in a new paper in the journal Proceedings of the National Academy of Sciences to explain why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.
› Verified 9 days ago
Tonya Nicole Kozminski, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250b Butler Cmns, Butler, PA 16001 Phone: 877-987-4368 Fax: 724-431-4307 | |
Emily Adams, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 E Brady St Ste 101, Butler, PA 16001 Phone: 833-684-1896 | |
Dale Ordean, CRNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Way, First Floor, Butler, PA 16001 Phone: 724-431-0550 Fax: 724-282-3043 | |
Surbhi Agarwal, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 E Brady St, Mccandless Corporate Center Building 111, Butler, PA 16001 Phone: 724-285-0823 | |
Dr. Elaine C Dischman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 256 New Castle Rd, Butler, PA 16001 Phone: 724-283-3627 Fax: 724-283-0968 | |
Mr. Thippeswamy T. Channapati, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 342 North Main Street, Butler, PA 16001 Phone: 724-282-8011 Fax: 724-282-3165 | |
Dr. George Thomas Lloyd, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 117 S Mckean St, Butler, PA 16001 Phone: 724-285-8888 Fax: 724-285-3030 |